BioCryst Pharmaceuticals shares owned by Citigroup
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.2M | 153k | 7.60 |
| 2024-06-30 | $722k | 117k | 6.18 |
| 2024-03-31 | $12M | 2.3M | 5.08 |
| 2023-12-31 | $7.1M | 1.2M | 5.99 |
| 2023-09-30 | $3.2M | 452k | 7.08 |
| 2023-03-31 | $5.5M | 660k | 8.34 |
| 2022-12-31 | $3.9M | 341k | 11.48 |
| 2022-09-30 | $7.0M | 475k | 14.71 |
| 2021-12-31 | $5.4M | 389k | 13.85 |
| 2021-03-31 | $3.7M | 362k | 10.17 |
| 2020-12-31 | $854k | 114k | 7.50 |
| 2020-09-30 | $271k | 75k | 3.60 |
| 2020-06-30 | $1.6M | 333k | 4.76 |
| 2020-03-31 | $314k | 158k | 1.99 |
| 2019-12-31 | $707k | 206k | 3.43 |
| 2019-09-30 | $1.1M | 368k | 2.87 |
| 2019-06-30 | $1.5M | 393k | 3.79 |
| 2019-03-31 | $275k | 34k | 8.13 |
| 2018-12-31 | $2.2M | 260k | 8.32 |
| 2018-09-30 | $1.1M | 148k | 7.72 |
| 2018-06-30 | $564k | 98k | 5.74 |
| 2018-03-31 | $690k | 145k | 4.77 |
| 2017-12-31 | $817k | 167k | 4.91 |
| 2017-09-30 | $222k | 42k | 5.25 |
| 2017-06-30 | $516k | 93k | 5.57 |
| 2017-03-31 | $133k | 16k | 8.38 |
| 2016-12-31 | $335k | 53k | 6.33 |
| 2016-09-30 | $14k | 2.7k | 5.00 |
| 2016-06-30 | $61k | 21k | 2.84 |
| 2015-12-31 | $257k | 25k | 10.36 |
| 2015-09-30 | $703k | 62k | 11.39 |
| 2015-06-30 | $423k | 28k | 14.91 |
| 2014-09-30 | $68k | 7.0k | 9.72 |
| 2014-03-31 | $92k | 8.6k | 10.66 |
| 2013-12-31 | $51k | 6.6k | 7.70 |
| 2013-09-30 | $15k | 2.0k | 7.50 |
| 2013-06-30 | $0 | 2.2k | 0.00 |